Theophylline clearance: Effect of marked obesity
暂无分享,去创建一个
[1] C. Litterst. In vitro hepatic drug metabolism and microsomal enzyme induction in genetically obese rats. , 1980, Biochemical pharmacology.
[2] J J Schentag,et al. Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. , 1979, Journal of pharmaceutical sciences.
[3] R. Blouin,et al. Tobramycin pharmacokinetics in morbidly obese patients , 1979, Clinical pharmacology and therapeutics.
[4] M. Ragni,et al. Theophylline pharmacokinetics in the young infant. , 1979, Pediatrics.
[5] Jerome J. Schentag,et al. Enhanced biotransformation of theophylline in marihuana and tobacco smokers , 1978, Clinical pharmacology and therapeutics.
[6] L. Hendeles,et al. Guide to oral theophylline therapy for the treatment of chronic asthma. , 1978, American journal of diseases of children.
[7] B. Franklin,et al. Theophylline disposition in obesity , 1978, Clinical pharmacology and therapeutics.
[8] R. Ogilvie,et al. Theophylline disposition in patients with hepatic cirrhosis. , 1977, The New England journal of medicine.
[9] R. Ogilvie,et al. Theophylline kinetics in acute pulmonary edema , 1977, Clinical pharmacology and therapeutics.
[10] J J Schentag,et al. System for clinical pharmacokinetic monitoring of theophylline therapy. , 1976, American journal of hospital pharmacy.
[11] A H Neims,et al. Pharmacokinetic aspects of theophylline in premature newborns. , 1976, The New England journal of medicine.
[12] H. Nagasawa,et al. Decreased theophylline half-life in cigarette smokers. , 1975, Life sciences.
[13] J. C. Brennan,et al. The Cardiac Pathology of Chronic Exogenous Obesity , 1965, Circulation.
[14] Harry L. Smith,et al. The relation of the weight of the heart to the weight of the body and of the weight of the heart to age , 1928 .
[15] S. Lohmann,et al. Theophylline metabolism by the rat liver microsomal system. , 1976, The Journal of pharmacology and experimental therapeutics.
[16] J. Alexander,et al. Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. , 1962, Cardiovascular Research Center bulletin.